US2807644A
(en)
|
1954-08-20 |
1957-09-24 |
Parke Davis & Co |
Pantethine inhibitors
|
DE1205972B
(de)
|
1963-08-20 |
1965-12-02 |
Merck Ag E |
Verfahren zur Herstellung eines Liponsaeure-derivates
|
FR1434130A
(fr)
*
|
1964-07-31 |
1966-04-08 |
Dausse Lab |
Sels de l'acide nu-cyclohexylsulfamique et leur procédé de préparation
|
US4011342A
(en)
|
1971-06-02 |
1977-03-08 |
Seperic |
Method and composition for the treatment of hypertension with ortho-disubstituted arylguanidines
|
GB1356470A
(en)
|
1971-06-02 |
1974-06-12 |
Seperic |
Ortho-disubstituted aryl-guanidines process for their preparation and applications thereof
|
AU514991B2
(en)
|
1976-05-26 |
1981-03-12 |
Commonwealth Of Australia, The |
Pharmaceutical compositions containing antiinflammatory analgesic compounds
|
JPS5412340A
(en)
|
1977-06-27 |
1979-01-30 |
Daito Koeki |
Process for preparing phenylacetate derivative
|
JPS5677259A
(en)
|
1979-11-29 |
1981-06-25 |
Nippon Chemiphar Co Ltd |
N-pyridoxyl 5,8,11,14,17-eicosapentaenoic acid amide, and its preparation
|
JPS57500432A
(da)
|
1980-03-20 |
1982-03-11 |
|
|
US4404366A
(en)
|
1980-05-06 |
1983-09-13 |
Miles Laboratories, Inc. |
Beta-galactosyl-umbelliferone-labeled hapten conjugates
|
US4412992A
(en)
|
1980-07-21 |
1983-11-01 |
Biorex Laboratories Limited |
2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith
|
US4440763A
(en)
|
1981-03-18 |
1984-04-03 |
Block Drug Company, Inc. |
Use of 4-aminosalicyclic acid as an anti-inflammatory agent
|
IT1190727B
(it)
|
1982-03-10 |
1988-02-24 |
Ausonia Farma Srl |
Composto ad attivita' analgesica,antiinfiammatoria e mucoregolatrice procedimento per la sua preparazione e relative composizioni farmaceutiche
|
FR2528038B2
(fr)
|
1982-06-04 |
1985-08-09 |
Lafon Labor |
Derives de benzhydrylsulfinylacetamide et leur utilisation en therapeutique
|
US4564628A
(en)
|
1983-01-03 |
1986-01-14 |
Nelson Research & Development Co. |
Substituted 2-aminotetralins
|
US5104887A
(en)
|
1983-02-04 |
1992-04-14 |
University Of Iowa Research Foundation |
Topical ophthalmic imino substituted 2-imino-3-methyl-delta4-1,3,4-thiadiazoline-5-sulfonamides carbonic anhydrase inhibitors
|
EP0151110B1
(en)
|
1983-08-01 |
1989-03-01 |
Astra Läkemedel Aktiebolag |
L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
|
JPS6089474A
(ja)
|
1983-10-20 |
1985-05-20 |
Toyo Pharma- Kk |
モルフイナン誘導体,その製造方法,及び該化合物を含有する抗腫瘍剤
|
IL73293A
(en)
|
1983-11-04 |
1988-02-29 |
Abbott Lab |
Methyl 2-(alkanamidoalkylsulfonic)ethylthiophosphonate derivatives
|
IT1213132B
(it)
|
1984-02-02 |
1989-12-14 |
Yason Srl |
Agente antibroncopneumopatico.
|
US4550109A
(en)
|
1984-05-31 |
1985-10-29 |
The Board Of Regents, The University Of Texas System |
Lipoidal biopterin compounds
|
JPS61277618A
(ja)
|
1985-06-04 |
1986-12-08 |
Suntory Ltd |
自閉症治療剤
|
YU213587A
(en)
|
1986-11-28 |
1989-06-30 |
Orion Yhtymae Oy |
Process for obtaining new pharmacologic active cateholic derivatives
|
US4873259A
(en)
|
1987-06-10 |
1989-10-10 |
Abbott Laboratories |
Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds
|
US5446070A
(en)
*
|
1991-02-27 |
1995-08-29 |
Nover Pharmaceuticals, Inc. |
Compositions and methods for topical administration of pharmaceutically active agents
|
US5102870A
(en)
|
1989-04-14 |
1992-04-07 |
Schering Ag |
Treatment and prevention of oral mucositis with growth factors
|
EP0421441B1
(en)
|
1989-10-06 |
1995-01-25 |
Fujirebio Inc. |
Pantothenic acid derivatives
|
US5242937A
(en)
|
1990-03-19 |
1993-09-07 |
Research Corporation Technologies, Inc. |
Topically active ocular thiadiazole sulfonamide carbonic anhydrase inhibitors
|
IT1248702B
(it)
|
1990-06-06 |
1995-01-26 |
Yason Srl |
Agente antitussivo e mucoregolatore,sua preparazione e composizioni farmaceutiche
|
FR2699077B1
(fr)
|
1992-12-16 |
1995-01-13 |
Rhone Poulenc Rorer Sa |
Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes.
|
FR2707637B1
(fr)
|
1993-06-30 |
1995-10-06 |
Lafon Labor |
Nouveaux dérivés d'acétamide, leur procédé de préparation et leur utilisation en thérapeutique.
|
EP0746557A4
(en)
|
1994-02-18 |
1997-05-02 |
Cell Therapeutics Inc |
INTRACELLULAR SIGNALING MEDIATORS
|
SE9401727D0
(sv)
|
1994-05-18 |
1994-05-18 |
Astra Ab |
New compounds I
|
FR2722199B3
(fr)
|
1994-07-11 |
1996-09-06 |
Univ Picardie Jules Verne Etab |
Derives de l'acide valproique et leurs applications comme medicaments
|
US6156777A
(en)
|
1994-12-15 |
2000-12-05 |
Pharmacia & Upjohn Company |
Use of pramipexole as a neuroprotective agent
|
NZ334389A
(en)
|
1996-08-28 |
2001-05-25 |
Ube Industries |
Cyclic amine derivatives
|
ATE296797T1
(de)
|
1996-11-22 |
2005-06-15 |
Elan Pharm Inc |
N-(aryl/heteroaryl/alkylacetyl) amino saüre amide,pharmazeutische zusammensetzungen damit, und methodenzur inhibierung beta-amyloid peptid freisetzung oder synthese
|
US6414008B1
(en)
|
1997-04-29 |
2002-07-02 |
Boehringer Ingelheim Pharma Kg |
Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions
|
GB9710351D0
(en)
|
1997-05-20 |
1997-07-16 |
Scotia Holdings Plc |
Glucosamine fatty acids
|
ES2343767T3
(es)
*
|
1997-09-18 |
2010-08-09 |
Pacira Pharmaceuticals, Inc. |
Composiciones anestesicas liposomicas de liberacion sostenida.
|
NZ333474A
(en)
|
1998-01-02 |
1999-06-29 |
Mcneil Ppc Inc |
A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
|
HU225741B1
(en)
|
1998-02-27 |
2007-07-30 |
Ube Industries |
Cyclic amino compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
|
JP3761324B2
(ja)
|
1998-05-15 |
2006-03-29 |
ヤンマー農機株式会社 |
乗用田植機
|
US6846495B2
(en)
|
1999-01-11 |
2005-01-25 |
The Procter & Gamble Company |
Compositions having improved delivery of actives
|
ES2305606T3
(es)
|
1999-04-06 |
2008-11-01 |
Sepracor Inc. |
Succinato de o-desmetilvenlafaxina.
|
US6262118B1
(en)
|
1999-06-04 |
2001-07-17 |
Metabolex, Inc. |
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
|
CN1211085C
(zh)
|
1999-09-29 |
2005-07-20 |
宝洁公司 |
稳定性改善的组合物
|
AU6972901A
(en)
|
2000-05-31 |
2001-12-11 |
Mayo Foundation |
Cobalamin compounds useful as cardiovascular agents and as imaging agents
|
US6429223B1
(en)
|
2000-06-23 |
2002-08-06 |
Medinox, Inc. |
Modified forms of pharmacologically active agents and uses therefor
|
WO2002009769A2
(en)
|
2000-07-27 |
2002-02-07 |
Rutgers, The State University Of New Jersey |
Therapeutic azo-compounds for drug delivery
|
AU2001296001A1
(en)
|
2000-10-24 |
2002-05-06 |
Ajinomoto Co., Inc. |
Process for producing b-form nateglinide crystal
|
DE10103506A1
(de)
|
2001-01-26 |
2002-08-14 |
Ingo S Neu |
Pharmazeutische Zusammensetzung zur Behandlung von Multiple Sklerose
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
FR2827517B1
(fr)
|
2001-07-23 |
2003-10-24 |
Bioalliance Pharma |
Systemes therapeutiques bioadhesifs a liberation prolongee
|
AU2002326806B2
(en)
|
2001-08-29 |
2007-07-19 |
Endo Pharmaceuticals, Inc. |
Analgetic pyrroline derivatives
|
US7138133B2
(en)
|
2001-10-10 |
2006-11-21 |
The Procter & Gamble Company |
Orally administered liquid compositions
|
US20040010038A1
(en)
|
2002-02-27 |
2004-01-15 |
Eran Blaugrund |
Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
|
US20030220344A1
(en)
|
2002-04-04 |
2003-11-27 |
Luiz Belardinelli |
Method of treating arrhythmias
|
JP4615866B2
(ja)
|
2002-04-15 |
2011-01-19 |
ノバルティス アーゲー |
N−(トランス−4−イソプロピルシクロヘキシルカルボニル)−d−フェニルアラニンの結晶形
|
EP1494669A1
(en)
|
2002-04-16 |
2005-01-12 |
Fujisawa Pharmaceutical Co., Ltd. |
Medicament for preventing and/or treating chronic rejection
|
US7060725B2
(en)
|
2002-05-13 |
2006-06-13 |
Janssen Pharmaceutica N.V. |
Substituted sulfamate anticonvulsant derivatives
|
GB0223224D0
(en)
|
2002-10-07 |
2002-11-13 |
Novartis Ag |
Organic compounds
|
AU2003293423A1
(en)
|
2002-12-06 |
2004-06-30 |
Xenoport, Inc. |
Carbidopa prodrugs and uses thereof
|
ATE405840T1
(de)
|
2002-12-19 |
2008-09-15 |
Scripps Research Inst |
Zusammensetzungen und verfahren zur stabilisierung von transthyretin und zur hemmung von transthyretin-fehlfaltung
|
DE602004015257D1
(de)
|
2003-02-14 |
2008-09-04 |
Pf Medicament |
Verwendung von dem (1s,2r)-milnacipran-enantiomer zur herstellung eines arzneimittels
|
UA81657C2
(ru)
|
2003-03-04 |
2008-01-25 |
Орто-Макнейл Фармасьютикел, Инк. |
Способ получения противосудорожных производных топирамата
|
JP2006520335A
(ja)
|
2003-03-18 |
2006-09-07 |
ノバルティス アクチエンゲゼルシャフト |
脂肪酸とアミノ酸を含有する組成物
|
PL1643999T3
(pl)
|
2003-06-20 |
2012-02-29 |
Nephrogenex Inc |
Pirydoksamina do zastosowania w leczeniu nefropatii cukrzycowej w cukrzycy typu II
|
KR20120116991A
(ko)
|
2003-07-29 |
2012-10-23 |
시그너쳐 알 앤드 디 홀딩스, 엘엘씨 |
아미노산 프로드럭
|
NZ546381A
(en)
|
2003-10-14 |
2010-01-29 |
Xenoport Inc |
Crystalline form of gamma-aminobutyric acid analog
|
US7470435B2
(en)
|
2003-11-17 |
2008-12-30 |
Andrx Pharmaceuticals, Llc |
Extended release venlafaxine formulation
|
WO2005051913A1
(ja)
|
2003-11-28 |
2005-06-09 |
Sankyo Company, Limited |
ヘテロアリール環を有する環状アミン誘導体
|
DE10361259A1
(de)
|
2003-12-24 |
2005-07-28 |
Schwarz Pharma Ag |
Verwendung von Rotigotine in einem Frühstadium von Morbus Parkinson zur Prävention des weiteren Neuronenverlustes
|
CN1248690C
(zh)
|
2004-03-25 |
2006-04-05 |
华中师范大学 |
一种治疗心血管疾病含盐酸雷诺嗪的口服制剂
|
CA2561672A1
(en)
|
2004-04-07 |
2005-12-08 |
The University Of Georgia Research Foundation, Inc. |
Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
|
JP5250257B2
(ja)
|
2004-04-29 |
2013-07-31 |
テイコク ファーマ ユーエスエー インコーポレーテッド |
メサドン局所組成物およびその使用方法
|
CN1672678A
(zh)
|
2004-05-03 |
2005-09-28 |
深圳微芯生物科技有限责任公司 |
预防和治疗前列腺疾病的长链脂肪酸天然活性成分的分离、提取和药用制剂的制备和应用
|
NZ551511A
(en)
|
2004-06-04 |
2010-09-30 |
Xenoport Inc |
Levodopa prodrugs, and compositions and uses thereof
|
CN100455560C
(zh)
|
2004-06-09 |
2009-01-28 |
中国人民解放军军事医学科学院放射医学研究所 |
含长链脂肪酰基取代的文拉法辛前体药物及其制备方法和用途
|
WO2006075125A1
(en)
|
2005-01-14 |
2006-07-20 |
Camurus Ab |
GnRH ANALOGUE FORMULATIONS
|
EP1863433A4
(en)
|
2005-03-18 |
2009-09-09 |
Ripped Formulations Ltd |
COMPOSITIONS AND METHODS FOR INCREASING METABOLISM, HEAT GENERATION AND / OR MUSCLE EDUCATION
|
US20080221111A1
(en)
|
2005-05-11 |
2008-09-11 |
Nycomed Gmbh |
Combination of a Pd4 Inhibitor and a Tetrahydrobiopterin Derivative
|
DE102005022276A1
(de)
|
2005-05-13 |
2006-11-16 |
Ellneuroxx Ltd. |
Derivate von Dihydroxyphenylalanin
|
US20060270635A1
(en)
|
2005-05-27 |
2006-11-30 |
Wallace John L |
Derivatives of 4- or 5-aminosalicylic acid
|
KR20080013944A
(ko)
|
2005-05-27 |
2008-02-13 |
다이이찌 산쿄 가부시키가이샤 |
치환 알킬기를 갖는 고리형 아민 유도체
|
CA2608432C
(en)
*
|
2005-05-27 |
2013-08-06 |
Royer Biomedical, Inc. |
Bioresorbable polymer matrices and methods of making and using the same
|
WO2006125293A1
(en)
|
2005-05-27 |
2006-11-30 |
Antibe Therapeutics Inc. |
Derivatives of 4- or 5-aminosalicylic acid
|
WO2007045620A1
(de)
|
2005-10-18 |
2007-04-26 |
Boehringer Ingelheim International Gmbh |
Verwendung von pramipexol zur behandlung des moderaten bis schweren restless legs syndroms (rls)
|
JPWO2007086493A1
(ja)
|
2006-01-27 |
2009-06-25 |
旭化成ファーマ株式会社 |
経鼻投与用薬剤
|
US20070259930A1
(en)
|
2006-04-10 |
2007-11-08 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
EP1870395A1
(en)
|
2006-06-19 |
2007-12-26 |
KRKA, D.D., Novo Mesto |
Process for preparation of o-desmethylvenlafaxine and its analogue
|
EP2046121B1
(en)
*
|
2006-07-14 |
2012-08-22 |
Stiefel Research Australia Pty Ltd |
Fatty acid pharmaceutical foam
|
US7943666B2
(en)
|
2006-07-24 |
2011-05-17 |
Trinity Laboratories, Inc. |
Esters of capsaicin for treating pain
|
US7645767B2
(en)
|
2006-08-31 |
2010-01-12 |
Trinity Laboratories, Inc. |
Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
|
TW200817048A
(en)
|
2006-09-08 |
2008-04-16 |
Wyeth Corp |
Dry powder compound formulations and uses thereof
|
CN100573950C
(zh)
|
2006-12-14 |
2009-12-23 |
财团法人工业技术研究院 |
相变存储装置及其制造方法
|
AU2007333050B2
(en)
|
2006-12-14 |
2013-08-29 |
Knopp Biosciences Llc |
Compositions and methods of using (R)-pramipexole
|
AU2007338631A1
(en)
|
2006-12-22 |
2008-07-03 |
Combinatorx, Incorporated |
Pharmaceutical compositions for treatment of parkinson's disease and related disorders
|
CA2675134A1
(en)
|
2007-01-12 |
2008-07-24 |
Biomarin Pharmaceutical Inc. |
Pterin analogs
|
ES2319024B1
(es)
|
2007-02-13 |
2009-12-11 |
Quimica Sintetica, S.A. |
Procedimiento para la obtencion de entacapona sustancialmente libre de isomero z, sus intermedios de sintesis y nueva forma cristalina.
|
CN101715443A
(zh)
|
2007-03-14 |
2010-05-26 |
诺普神经科学股份有限公司 |
手性纯化的取代的苯并噻唑二胺的合成
|
US7973049B2
(en)
|
2007-05-01 |
2011-07-05 |
Concert Pharmaceuticals Inc. |
Morphinan compounds
|
EP1997493A1
(en)
|
2007-05-28 |
2008-12-03 |
Laboratorios del Dr. Esteve S.A. |
Combination of a 5-HT7 receptor ligand and an opioid receptor ligand
|
CA2690776A1
(en)
|
2007-06-22 |
2008-12-31 |
Gluconova Llc |
Halide-free glucosamine-acidic drug complexes
|
US20090075942A1
(en)
|
2007-09-13 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched fosamprenavir
|
CN101390854A
(zh)
|
2007-09-21 |
2009-03-25 |
北京德众万全药物技术开发有限公司 |
一种含有利鲁唑的药用组合物
|
US20090093547A1
(en)
*
|
2007-10-09 |
2009-04-09 |
Sciele Pharma, Inc. |
Compositions and Methods for Treating Premature Ejaculation
|
WO2009056791A1
(en)
|
2007-11-02 |
2009-05-07 |
Pliva Hrvatska D.O.O. |
Processes for preparing pharmaceutical compounds
|
US20090118365A1
(en)
|
2007-11-06 |
2009-05-07 |
Xenoport, Inc |
Use of Prodrugs of GABA B Agonists for Treating Neuropathic and Musculoskeletal Pain
|
WO2009061497A1
(en)
*
|
2007-11-07 |
2009-05-14 |
Svip5 Llc |
Slow release of organic salts of local anesthetics for pain relief
|
CN103239721B
(zh)
*
|
2007-11-22 |
2016-03-16 |
美德阿利克斯株式会社 |
包括基于脂肪酸的离子型液体作为活性成分的外用制剂组合物
|
CN101186583B
(zh)
|
2007-12-20 |
2011-05-11 |
吉林大学 |
2-(2-(2,6-二氯苯基氨基)苯基)醋酸甲酯及其合成方法及其应用
|
WO2009100441A2
(en)
*
|
2008-02-08 |
2009-08-13 |
Impax Laboratories, Inc. |
Depot formulations
|
US20100081713A1
(en)
|
2008-03-19 |
2010-04-01 |
CombinatoRx, (Singapore) Pte. Ltd. |
Compositions and methods for treating viral infections
|
CN102512405B
(zh)
|
2008-04-30 |
2015-08-05 |
上海医药工业研究院 |
一类长链脂肪酸衍生物或含其的植物提取物在制备抑制芳香化酶活性的药物中的应用
|
KR100990949B1
(ko)
|
2008-06-09 |
2010-10-29 |
엔자이텍 주식회사 |
클로피도그렐 및 그의 유도체의 제조방법
|
EP2813486B1
(en)
|
2008-07-08 |
2017-10-25 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid acetylated salicylates and their uses
|
JP5544544B2
(ja)
*
|
2008-08-05 |
2014-07-09 |
株式会社 メドレックス |
塩基性薬効成分の脂肪酸塩、安息香酸塩を含有する外用剤とその製造方法
|
EP2334378B1
(en)
|
2008-08-19 |
2014-04-09 |
XenoPort, Inc. |
Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
|
AU2009283813B2
(en)
|
2008-08-22 |
2015-02-19 |
Wockhardt Research Centre |
An extended release pharmaceutical composition of entacapone or salts thereof
|
EP2165706A1
(en)
|
2008-09-18 |
2010-03-24 |
BioAlliance Pharma |
Treating Inflammatory Pain in Mucosa of the Oral Cavity Using Mucosal Prolonged Release Bioadhesive Therapeutic Carriers.
|
US20110313176A1
(en)
|
2008-12-26 |
2011-12-22 |
Actavis Group Ptc Ehf |
Processes for preparing highly pure rotigotine or a pharmaceutically acceptable salt thereof
|
BRPI0901298A2
(pt)
|
2009-04-06 |
2011-01-04 |
Ems Sa |
derivados ftalimìdicos de compostos antiinflamatórios não-esteróide e/ou moduladores de tnf-(alfa), processo de sua obtenção, composições farmacêuticas contendo os mesmos e seus usos no tratamento de doenças inflamatórias
|
CN101559077A
(zh)
*
|
2009-04-16 |
2009-10-21 |
官培龙 |
一种口腔炎症性疾病止痛用含漱液
|
AU2010241567B2
(en)
|
2009-04-29 |
2013-10-31 |
Amarin Pharmaceuticals Ireland Limited |
Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the same
|
WO2010147666A1
(en)
|
2009-06-19 |
2010-12-23 |
Memorial Sloan-Kettering Cancer Center |
Compounds useful as carbonic anhydrase modulators and uses thereof
|
JP2013501733A
(ja)
|
2009-08-10 |
2013-01-17 |
ビーエイチアイ リミテッド パートナーシップ |
1,3−プロパンジスルホン酸を送達するための方法、化合物、および組成物
|
CN102002053A
(zh)
|
2009-09-02 |
2011-04-06 |
陕西合成药业有限公司 |
用于治疗的四氢噻吩并吡啶衍生物
|
CN101717392A
(zh)
|
2009-10-09 |
2010-06-02 |
苏州凯达生物医药技术有限公司 |
一种制备罗替戈汀及其衍生物的方法
|
CN102050815B
(zh)
|
2009-11-06 |
2014-04-02 |
北京美倍他药物研究有限公司 |
作为前药的达比加群的酯衍生物
|
CN101724934B
(zh)
|
2009-11-10 |
2012-07-04 |
东华大学 |
一种用于治疗皮肤炎症和疼痛的药用纤维及其制备和应用
|
ES2364011B1
(es)
|
2009-11-20 |
2013-01-24 |
Gp Pharm, S.A. |
Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
|
DK2521447T3
(da)
|
2010-01-08 |
2017-09-18 |
Catabasis Pharmaceuticals Inc |
Fedtsyrefumarater og deres anvendelser
|
EP2525830B1
(en)
|
2010-01-22 |
2016-05-11 |
Ascendis Pharma A/S |
Dipeptide-based prodrug linkers for aliphatic amine-containing drugs
|
RU2436772C2
(ru)
|
2010-01-28 |
2011-12-20 |
Закрытое акционерное общество "НПК ЭХО" |
4[(4'-никотиноиламино)бутироиламино]бутановая кислота, проявляющая ноотропную активность, и способ ее получения
|
US20130190327A1
(en)
|
2010-02-26 |
2013-07-25 |
Catabasis Pharmaceuticals Inc |
Bis-fatty acid conjugates and their uses
|
JP5412340B2
(ja)
|
2010-03-19 |
2014-02-12 |
本田技研工業株式会社 |
車両の視認窓
|
BR112012031194A2
(pt)
|
2010-06-08 |
2018-05-29 |
Krisani Biosciences P Ltd |
derivados de cisteamina e seu uso no tratamento de ehna
|
BR112013000537B1
(pt)
|
2010-07-12 |
2021-07-27 |
Boehringer Ingelheim International Gmbh |
Composição aquosa contendo bromexina e seu uso
|
WO2012025213A2
(en)
|
2010-08-23 |
2012-03-01 |
Grünenthal GmbH |
Novel therapeutic compounds
|
WO2012027543A1
(en)
|
2010-08-25 |
2012-03-01 |
Teva Pharmaceuticals Usa, Inc. |
Solid state forms of dabigatran etexilate, dabigatran etexilate mesylate and processes for preparation thereof
|
CN101921245B
(zh)
|
2010-08-30 |
2012-04-18 |
中国人民解放军军事医学科学院卫生学环境医学研究所 |
抑制碳酸酐酶ⅱ的磺胺类化合物及合成方法与用途
|
SI2632451T1
(en)
|
2010-10-29 |
2018-02-28 |
Algiax Pharmaceuticals Gmbh |
Use of malononitrilamides in neuropathic pain
|
EP2450039A1
(en)
|
2010-11-08 |
2012-05-09 |
PAION UK Ltd. |
Dosing regimen for sedation with CNS 7056 (Remimazolam)
|
WO2012115695A1
(en)
|
2011-02-25 |
2012-08-30 |
Catabasis Pharmaceuticals, Inc. |
Bis-fatty acid conjugates and their uses
|
SI2701681T1
(sl)
*
|
2011-04-29 |
2017-01-31 |
Moberg Pharma Ab |
Farmacevtski sestavki, ki obsegajo lokalen anestetik kot bupivakain, za lokalno aplikacijo v usta ali grlo
|
WO2013008182A1
(en)
|
2011-07-10 |
2013-01-17 |
Mahesh Kandula |
Prodrugs of gaba analogs
|
CN102336767A
(zh)
|
2011-07-11 |
2012-02-01 |
华东理工大学 |
制备高纯度手性α-取代-6,7-二氢噻吩并[3,2-c]吡啶衍生物的方法
|
WO2013017974A1
(en)
|
2011-07-30 |
2013-02-07 |
Mahesh Kandula |
Compositions and methods for the treatment of neuromuscular disorders and neurodegenerative diseases
|
WO2013024376A1
(en)
|
2011-08-16 |
2013-02-21 |
Mahesh Kandula |
Compositions and methods for the treatment of atherothrombosis
|
WO2013027150A1
(en)
|
2011-08-21 |
2013-02-28 |
Mahesh Kandula |
Compositions and methods for the treatment of parkinson's disease
|
CN102633799B
(zh)
|
2012-04-10 |
2014-06-25 |
凯莱英医药集团(天津)股份有限公司 |
一种从消旋体中间体拆分路线合成二盐酸沙丙蝶呤的方法
|
US9434704B2
(en)
|
2012-05-08 |
2016-09-06 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurological degenerative disorders
|
US20150133533A1
(en)
|
2012-05-08 |
2015-05-14 |
Mahesh Kandula |
Compositions and methods for the treatment of cough
|
WO2013168022A1
(en)
|
2012-05-08 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for treating atherothrombosis
|
JP2015521184A
(ja)
|
2012-05-10 |
2015-07-27 |
セリックスビオ プライヴェート リミテッド |
メタボリック症候群の治療のための組成物と治療法
|
SG11201407326XA
(en)
|
2012-05-23 |
2014-12-30 |
Cellix Bio Private Ltd |
Compositions and methods for treatment of mucositis
|
WO2014061497A1
(ja)
*
|
2012-10-16 |
2014-04-24 |
コニカミノルタ株式会社 |
フィルムミラー及び太陽熱発電用反射装置
|
WO2014091384A2
(en)
*
|
2012-12-12 |
2014-06-19 |
Mahesh Kandula |
Compositions and methods for the treatment of mucositis
|
WO2014160026A2
(en)
*
|
2013-03-14 |
2014-10-02 |
Endo Pharmaceuticals Solutions Inc. |
Implantable drug delivery compositions comprising sugar-based sorption enhancers and methods of treatment thereof
|
WO2014174425A2
(en)
|
2013-04-24 |
2014-10-30 |
Mahesh Kandula |
Compositions and methods for the treatment of orthostasis and neurological diseases
|
SG11201509782TA
(en)
|
2013-06-04 |
2015-12-30 |
Cellix Bio Private Ltd |
Compositions and methods for the treatment of diabetes and pre-diabetes
|
SG11201705524SA
(en)
*
|
2015-01-06 |
2017-08-30 |
Cellix Bio Private Ltd |
Compositions and methods for the treatment of inflammation and pain
|